Login to Your Account

Two German Kinase Companies Merge, Bring In EUR11M Financing

By Douglas Merrill

Wednesday, January 28, 2004
MUNICH, Germany - Two young Munich biotechnology companies - Nadag AG and Sireen AG - merged to form Sirenade Pharmaceuticals AG, which will focus on oncology and central nervous system conditions. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription